Rxcurve
HCPCS J1939 · per 0.5 MG

Inj, bumetanide, 0.5 mg

Products billed under this code include Bumetanide.

Payment limit per 0.5 MG, by effective quarter, 1Q24 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J1939

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Bumetanide Hikma Pharmaceuticals USA Inc. 00641-6007-10 50 $24.65
Bumetanide Hikma Pharmaceuticals USA Inc. 00641-6008-10 20 $9.86
Bumetanide Hikma Pharmaceuticals USA Inc. 00641-6161-10 20 $9.86
Bumetanide Hikma Pharmaceuticals USA Inc. 00641-6162-10 50 $24.65
Bumetanide Hikma Pharmaceuticals USA Inc. 00641-6284-10 20 $9.86
Bumetanide Hikma Pharmaceuticals USA Inc. 00641-6285-10 50 $24.65
Bumetanide Sagent Pharmaceuticals 25021-0321-04 20 $9.86
Bumetanide Sagent Pharmaceuticals 25021-0321-10 50 $24.65
Bumetanide FreseniUS Kabi USA, LLC 65219-0570-04 20 $9.86
Bumetanide FreseniUS Kabi USA, LLC 65219-0572-10 50 $24.65
Show all 21 products
ProductLabelerNDCUnits / pkgLimit / pkg
Bumetanide Glenmark Pharmaceuticals Inc., USA 68462-0469-54 20 $9.86
Bumetanide Glenmark Pharmaceuticals Inc., USA 68462-0470-54 50 $24.65
Bumetanide Lupin Pharmaceuticals, Inc. 70748-0323-10 20 $9.86
Bumetanide Lupin Pharmaceuticals, Inc. 70748-0323-11 50 $24.65
Bumetanide Athenex Pharmaceutical Division, LLC 70860-0406-10 50 $24.65
Bumetanide Novadoz Pharmaceuticals LLC 72205-0101-07 20 $9.86
Bumetanide Novadoz Pharmaceuticals LLC 72205-0102-07 50 $24.65
Bumetanide Civica, Inc. 72572-0040-10 20 $9.86
Bumetanide Civica, Inc. 72572-0041-10 50 $24.65
Bumetanide Mullan Pharmaceutical Inc. 83301-0080-02 20 $9.86
Bumetanide Mullan Pharmaceutical Inc. 83301-0081-02 50 $24.65

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $0.493 −$0.005 0.5 MG Inj, bumetanide, 0.5 mg v1, posted September 17, 2026
3Q26 $0.498 −$0.044 0.5 MG Inj, bumetanide, 0.5 mg v1, posted September 15, 2026
2Q26 $0.542 +$0.036 0.5 MG Inj, bumetanide, 0.5 mg v1, posted September 15, 2026
1Q26 $0.506 −$0.037 0.5 MG Inj, bumetanide, 0.5 mg v1, posted September 15, 2026
4Q25 $0.543 −$0.065 0.5 MG Inj, bumetanide, 0.5 mg v1, posted September 8, 2026
3Q25 $0.608 +$0.039 0.5 MG Inj, bumetanide, 0.5 mg v1, posted March 10, 2026
2Q25 $0.569 −$0.01 0.5 MG Inj, bumetanide, 0.5 mg v1, posted March 10, 2026
1Q25 $0.579 −$0.041 0.5 MG Inj, bumetanide, 0.5 mg v1, posted December 19, 2025
4Q24 $0.62 +$0.005 0.5 MG Inj, bumetanide, 0.5 mg v1, posted June 11, 2025
3Q24 $0.615 −$0.017 0.5 MG Inj, bumetanide, 0.5 mg v1, posted June 11, 2025
2Q24 $0.632 −$0.033 0.5 MG Inj, bumetanide, 0.5 mg v1, posted March 11, 2025
1Q24 $0.665 – 0.5 MG Inj, bumetanide, 0.5 mg v1, posted December 19, 2024

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files